Stryker MedSurg and Neurotechnology — Total Assets increased by 1.4% to $27.28B in Q3 2025 compared to the prior quarter.
An increase suggests expansion of the asset base, while a decrease may indicate divestitures or more efficient asset management.
Represents the total economic resources controlled by the MedSurg and Neurotechnology segment, including inventory, prop...
Standard balance sheet metric for segment reporting, comparable across manufacturing-heavy industries.
syk_segment_medsurg_and_neurotechnology_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|
| Value | $15.22B | $18.28B | $20.51B | $23.12B | $26.91B | $26.91B | $27.28B |
| QoQ Change | — | +20.1% | +12.2% | +12.7% | +16.4% | -0.0% | +1.4% |
| YoY Change | — | +20.1% | +12.2% | +12.7% | — | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.